Dishing it out on mHealth hype

Categories: Latest News.

In his latest blog post Eric Dishman reveals more of the man behind the Intel healthcare empire (or mini-empire, depending on your perspective). He’s commenting on the bandwagon that is ‘mHealth’,with its rag-bag of definitions and puts in a plea for some ‘old school’ rigor when it comes to evidence of effectiveness. “…not every mHealth application or service requires a randomized, clinical trial to prove its worth, but some kind of evidence is warranted.”. The Hype and Hope of “mHealth”.

[Ed. Donna for Steve:  Do read David Doherty’s comment which links to his lengthy blog post–your holiday reading–for a contrarian view on Mr. Dishman and Intel.]

Comments

  1. David Doherty, mHealthInsight

    The hype and hope of Intel Health’s product portfolio…
    Hi Steve, You might like to check out my detailed (read: long and boring) response to Eric’s post: http://bit.ly/bRqnzx I think you’ll agree it’s easy to appreciate his perspectives when you consider the rather disappointing, expensive and already outdated products being marketed by Intel Health.